Precision Immuno-Oncology in NSCLC through Gender Equity Lenses

By sjmartinez • April 14, 2024

Marks J, Sridhar A, Ai A, Kiel L, Kaufman R, Abioye O, Mantz C, Florez N. Precision Immuno-Oncology in NSCLC through Gender Equity Lenses. Cancers (Basel). 2024 Apr 4;16(7):1413. doi: 10.3390/cancers16071413. PMID: 38611091; PMCID: PMC11010825.

Tags: clinical trials, Female, General Internal Medicine, immunotherapy, NSCLC, Olive View DoM, precision oncology, Publications, underrepresentation, Women

Sequencing of anti-CD19 therapies in the management of diffuse large B-cell lymphoma

Lownik J, Boiarsky J, Birhiray R, Merchant A, Mead M. Sequencing of anti-CD19 therapies in the management of diffuse large B-cell lymphoma. Clin Cancer Res.[...]

Outpatient hospitalist-run procedure service bridges the gap in oncology care

Ghanem G, Tsai HHC, Durant C, Feigenbaum GS, Glaeser AM. Outpatient hospitalist-run procedure service bridges the gap in oncology care. Transfus Apher Sci. 2024 Apr[...]

Statewide Survey of Primary Care and Subspecialty Providers on Hepatocellular Carcinoma Risk-Stratification and Surveillance Practices

Moon AM, Swier RM, Lane LM, Barritt AS 4th, Sanoff HK, Olshan AF, Wheeler SB, Ioannou GN, Kim NJ, Hagan S, Vutien P, Benefield T,[...]